StockWatch
·
SAMHI HOTELS LTD · QQ1 FY-2027 · THE CALL

Occupancy resilient, but rate growth muted; FY28 targets push back

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsSAMHISamhi Hotels Ltd17 Aug 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade A

Hit 9-11% same-store guidance with 9.1% delivery; finance costs down 25.5%; maintained long-term guidance despite headwinds. Track record intact.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Delivered on same-store growth (9.1% vs. 9-11% guide), but rate growth stalled (2.6-2.7%) as international travel remained disrupted. Occupancy strength (79.3%) and domestic resilience (82% mix) have cushioned top-line, but F&B weakness (3.7%) and GST headwinds (₹9.2 Cr Q1 impact) compress margins near-term. Management realistic on macro, confident on multi-year trajectory; FY28 leverage target more credible than FY27.

₹305.2 Cr

Revenue · +12.1% YoY

₹24.9 Cr

Reported PAT · +29.7% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Same-store RevPAR growth 9.6% YoY within 9-11% guidance

MET

Delivered 9.1% comparable same-store revenue growth (call states same-store RevPAR 9.6%)

Comparable revenue growth 10.8% excluding one-time items

MET

Delivered revenue 305.2 Cr +12.1% YoY; call adjusts for Rs. 9.3 Cr one-time other income Q1 FY26

Finance costs declined 25.5% to Rs. 37.7 Cr driving PBT +26.4%

MET

Delivered PAT +29.7% YoY; call shows PBT +26.4% pre-tax, consistent with deleveraging progress

ADR flat last quarter, only 2.6-2.7% this quarter, lowest in two quarters

MET

International arrivals disrupted by West Asia crisis; domestic mix up to 82%; rate recovery deferred

Reported EBITDA down 4% YoY but comparable basis healthy 12.1%

MET

Reported EBITDA-negative margin impact from Rs. 9.2 Cr GST regime change (12% ITC → 5% no ITC), verified

Earnings quality

What changed since the last call

Deltas vs. the prior call

Leverage target timeline extended

Downgrade

Prior: 2.5x net debt-to-EBITDA within 12-18 months (from FY26 call). Now: FY28 (next year). Current 3.2x trailing, 2.4x operating basis.

ADR growth deceleration

Downgrade

Q4 FY26 flat, Q1 FY27 +2.6-2.7% vs. historical double-digit; West Asia crisis hollowed international premium (10-20% on rates)

RARE capital commitment confirmed

New

Rs. 47 Cr invested (disclosed new: Itmenaan +Rs. 12 Cr estate = Rs. 60 Cr total); targeting Rs. 35-40 Cr EBITDA in 2 yr with 5x ROCE potential

Cash generation path reaffirmed

Neutral

Rs. 3,000 Cr cumulative FCF FY27-31 (management clarified Rs. 3,000 not Rs. 2,000); funds committed pipeline + optionality via Rs. 750 Cr enabling resolution

The Q&A

Analysts pressed ADR softness, GST impact, fundraise rationale, RARE ROI, Navi Mumbai delays. Management held firm on occupancy resilience (79%), domestic strength (82%), H2 rate recovery (July early data positive), and multi-year path. No major concessions; acknowledged macro uncertainty but did not project recovery timeline.

The exchanges that mattered

RARE capital allocation — Karan Khanna, Ambit Capital

Answered

RARE asset-light; incremental capital negligible. Total allocation stays ~10-12% zip code. Value creation disproportionate; arbitrage in capital vs. room rates (experiences/distribution-driven).

FY27 growth composition — Karan Khanna, Ambit Capital

Partial

H1 occupancy-driven, H2 rebalances domestic/international for rate recovery. July stronger; seeing rate growth now. But one month not representative.

RARE Marriott uptake — Jinesh Joshi, Prabhudas Lilladher

Answered

Sign-ups ahead of expectation. Pace constrained by prior platform contracts (10-12 hotels), property reviews, licensing. No issue with hoteliers.

Fundraise rationale — Jinesh Joshi, Prabhudas Lilladher

Answered

Board optionality for uncertainties (geopolitical shocks, unexpected M&A). Financial discipline + balance sheet strength non-negotiable. Precedent in capital-intensive sectors.

ADR softness analysis — Vikas Ahuja, Antique Stock Broking

Answered

79% occupancy is strong, not soft. West Asia crisis disrupted international (10-15% premium lost). Focus on same-store revenue, not ADR alone. H2 rate recovery expected as crisis stabilizes.

F&B revenue decline — Vaibhav Muley, Haitong India Securities

Answered

International mix down (78-79% to 80-83% domestic). Restaurant renovation in Bangalore. Event cancellations moved to July-Aug. Will recover as events pick pace and mix rebalances.

GIC partnership scope — Vaibhav Muley, Haitong India Securities

Answered

GIC has 35% right in new upscale post-JV agreement. Navi Mumbai, W Hyderabad 100% SAMHI (seeded prior to GIC JV). IKEA-Ingka Noida only opportunity signed since GIC deal.

Segment-wise rate dynamics — Shrinjana Mittal, MS Capital

Partial

Raw ARR flat 3.5-4% across all segments. Midscale outperformed on RevPAR (+13.7%) due to 81.3% occupancy vs. upscale 78.4%. Upscale recovering; Q2+ trends 'far ahead' of Q1.

GST impact clarity — Shrinjana Mittal, MS Capital

Answered

Midscale volume-driven Q1-Q2; GST impact larger. Q3 onward equalizes YoY (prior also bears 5% regime). But H2 impact <H1. Closer to 2% expected.

RARE revenue model — Karan Gupta, Asit C Mehta Investment

Answered

Fee/commission on bookings. Some hotels offer extended agreements (revenue share model). Fee income recognised as SAMHI revenue. Hotel owner keeps room revenue. Commission on booking channels.

RARE margin and ROI — Karan Gupta, Asit C Mehta Investment

Answered

Stabilized: Rs. 100-120 Cr topline, ~35% margin (EBITDA Rs. 35-40 Cr), 100% NOI yield on Rs. 47 Cr investment in ~2 years. Core ROCE ~18-19%; asset-light should be 2-3x, targeting 50-55%.

RARE ROCE potential — Viraj Mahadevia, Moneygrow Asset

Answered

Not double; should do ~5x. Rs. 47 Cr invested earning Rs. 35-40 Cr EBITDA, minimal depreciation/finance cost; 95% flow-through to PBT. Expecting 50-55% ROCE.

EBITDA bridge disconnect — Viraj Mahadevia, Moneygrow Asset

Answered

Q1 FY26 had Rs. 9 Cr other income (GIC revaluation). Rs. 9.2 Cr GST impact Q1. Comparable basis shows revenue +11%, EBITDA +12.5%. Q2 eliminates one-time, Q3 eliminates GST; will normalize.

Net debt-to-EBITDA trajectory — Viraj Mahadevia, Moneygrow Asset

Answered

No. Target is FY28, not FY27. Driven by stable net debt + EBITDA growth. More credible timeline given current 3.2x.

Enabling resolution investor concerns — Bharat Gianani, MC Research

Partial

Precedent in capital-intensive sectors; protects optionality. Cannot disclose mix (enabling only, not deliberated). Focus on balance sheet discipline, opportunities via distressed acquisitions.

M&A economics post-peak — Bharat Gianani, MC Research

Answered

Target operational distress deals (renovation, rebranding, management turnaround). Even in peak cycles, Bangalore Whitefield, Hyderabad, Noida opportunities found. ROCE discipline maintained.

Navi Mumbai project status — Ashish, Leo Capital

Answered

All prior issues fully resolved. Statutory approvals progressing (first set in coming months). Design development next quarter. Groundbreaking 1st Apr 2027. Delivery 3-4 years. Capital ramp FY29-30 (FY28 small).

Guidance

Forward guidance and management's confidence

FY27 same-store revenue growth 9-11%

High

Delivered 9.1% comparable growth Q1. Reaffirmed on call. Headwinds (West Asia, ADR softness) acknowledged but domestic resilience (82% mix, 79% occupancy) supportive. H2 rate recovery expected as international stabilizes.

1,660 rooms across 7 new hotels committed pipeline

Medium

W Hyderabad S2 FY28, Courtyard Pune back-office renovation ongoing, Navi Mumbai groundbreaking Apr 2027 (3-4 yr delivery, capex ramp FY29-30). Regulatory/execution risk flagged.

EBITDA margin 'significantly improving' multi-year

Medium

Near-term: GST headwind ~Rs. 9.2 Cr Q1, continues H1 (lesser), eases Q3. Upscale mix shift (60% by FY30) immune to GST (5% rate); midscale gets hit. Comparable EBITDA +12.1% on operational leverage.

OPM 32.2% delivered (NPM 8.1%)

High

Reasonable given financing costs. Multi-year leverage to 2.5x will reduce finance burden. New upscale hotels higher-margin; portfolio mix shift accretive.

Rs. 3,000 Cr cumulative FCF FY27-31 to fund growth CAPEX + deleveraging

High

Rs. 300+ Cr annual FCF target (internal accrual-funded). Navi Mumbai (largest project, dual-branded, 3-4 yr delivery) capex-heavy FY29-30 (post-RCC structure); FY28 capex small. Committed pipeline Rs. 1,660 rooms.

Risks the call surfaced

Ranked by how much they should concern a holder

International travel disruption

High

West Asia geopolitical crisis reduced international arrivals; international travelers premium 10-20% on rates, 15-20% on F&B. International mix fell from ~22% to ~18% room nights. ADR growth stalled at 2.6-2.7%.

GST regime headwind

High

GST regime changed from 12% with input tax credit to 5% without ITC on rooms ≤₹7,500/night. Midscale (23% of revenue) disproportionately hit. Rs. 9.2 Cr negative impact Q1; continues Q2, eases from Q3 (prior-year comparison normalizes).

Leverage trajectory

Medium

Net debt-to-EBITDA at 3.2x (trailing 12M) vs. 2.5x target. Management clarified target pushed to FY28 (not FY27). Requires Rs. 550 Cr annualized EBITDA run-rate to hit target; currently Rs. 100 Cr quarterly (~Rs. 400 Cr annualized), needs ~37.5% growth.

Project execution & regulatory delays

High

Navi Mumbai (flagship dual-branded project, 3-4 yr delivery) groundbreaking slipped to Apr 2027 (from 'end of FY27'). Regulatory approvals remain risk; first set expected in coming months. W Hyderabad S2 FY28; Courtyard Pune renovation ongoing. Capex ramp concentrated FY29-30.

RARE early-stage economics

Medium

RARE invested Rs. 47 Cr (now Rs. 60 Cr with Itmenaan), targeting Rs. 35-40 Cr EBITDA in next 2 years. Portfolio of 75 hotels with 40 on Marriott Outdoor Collection; only 53% enrolled. Model depends on commission income + fee expansion. Hotels operate at Rs. 15K-70K ARR; occupancy 25-75%; heterogeneous.

Equity dilution overhang

Medium

Rs. 750 Cr enabling resolution passed; management signals annual practice going forward. Overhang of dilution unnerves investors. GIC platform (35% right on new upscale) + enabling resolution together create unclear capital allocation path. Promoter holding slightly lower.

Management

Score 7/10. Transparent on headwinds (West Asia, ADR softness, GST impact). Candid about leverage target timeline (pushed to FY28). Good granularity on segment performance, RARE model, project status. Evasive on fundraise mix (equity/debt) and exact RARE capital % (defended 10-12% threshold). Hit 9-11% same-store growth Q1 (9.1% delivered) despite disruptions. Finance costs down 25.5%; maintained credit rating A+ stable. Executed RARE expansion (66→75 hotels), Marriott partnership (40/75 enrolled). Navi Mumbai on track (groundbreaking Apr 2027). Track record A-grade.

What to watch next
  • 1 · Q2 FY27

    GST YoY comparison normalizes; W Asia stabilization may unlock rate growth

  • 2 · Q3/Q4 FY27

    GST impact eases (prior period also bears same regime); margin recovery visible

  • 3 · Q2+ FY28

    W Hyderabad opens (S2 FY28, post-June 2028); upscale mix shift accretive to margins

Management realistic on macro, confident on multi-year trajectory; FY28 leverage target more credible than FY27.

Informational and educational content only. Not investment advice.